HK Stock MarketDetailed Quotes

08622 HUAKANG BIOMED

Watchlist
  • 0.153
  • +0.020+15.04%
Market Closed Dec 13 16:08 CST
76.57MMarket Cap-11.77P/E (TTM)

About HUAKANG BIOMED Company

Huakang Biomedical Holdings Co., Ltd. is a medical device group focusing on R&D, production and sales of various in vitro diagnostic reagents in China. With our knowledge and experience, the Group focuses on the male infertility in vitro diagnostic reagent market in China. According to the Insight Consulting Report, in terms of procurement value for medical institutions, we ranked third among Chinese male infertility in vitro diagnostic reagents in 2017, accounting for 14.3% of the market share. We have developed a diversified product portfolio of male infertility in vitro diagnostic reagents, which registered the highest number of products with the China Food and Drug Administration and the provincial Food and Drug Administration among all manufacturers in 2017. One of our parasite series detection reagents is one of only two in vitro diagnostic reagents for liver schistosomiasis that has been approved by the China Food and Drug Administration for production and sale in China. Shenzhen Huakang Biomedical Engineering Co., Ltd. (previously known as Shenzhen Moon Bay Biotechnology Co., Ltd. and Shenzhen Nan Fung Biotechnology Co., Ltd.), a limited company established on June 26, 1992 in accordance with Chinese law, is a wholly-owned subsidiary of the Company. Our in vitro diagnostic reagent product portfolio includes: (i) In vitro diagnostic reagents for male infertility (ii) Parasite series test reagents and (iii) A combination of in vitro diagnostic reagents including EBV detection reagents. R & D capability is one of our main competitive advantages. In 2011, we were first recognized as a “National High-tech Enterprise” by relevant Chinese government agencies. We sell our products in China through direct sales and our distributors to hospitals and medical institutions, which use our products for clinical diagnostic tests.

Company Profile

Symbol08622
Company NameHUAKANG BIOMED
ISINKYG4644W1069
Listing DateDec 13, 2018
Issue Price0.50
Shares Offered100.00M share(s)
FoundedAug 3, 2017
Registered AddressCayman Islands
Chairmanshuguang zhang
Secretaryliqi zhou
Audit InstitutionCCA Zhonghuan (Hong Kong) Certified Public Accountants Limited
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 04, 9th Floor, Kimberley Centre, 35-35A Kimberley Road, Tsim Sha Tsui, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees90
MarketGEM
Phone(0755)32833299
Fax(0755)33853879
Emailhuakang@szhuakang.com
Business The Group is a medical device group focusing on the R&D, production and sale of various in vitro diagnostic reagents and reproductive aid products and equipment in China.

Company Executives

  • Name
  • Position
  • Salary
  • shuguang zhang
  • Presidencies, Executive Director, Chairman of the Nomination Committee, Authorized Representative
  • 479.00K
  • chunguang zhang
  • CEO, Executive Director, Remuneration Committee Members
  • 703.00K
  • lixian pan
  • Executive Director, Chief Financial Officer, Compliance Officer, Authorized Representative
  • 769.00K
  • jiaming he
  • Executive Director
  • 484.00K
  • su bo
  • Non-executive Directors
  • --
  • guohui zhou
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 90.00K
  • ming xu
  • Non-executive Directors
  • --
  • meiling shi
  • Independent Non-Executive Director
  • --
  • fading zheng
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Chairman
  • 90.00K
  • jingwen zhou
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members
  • 38.00K
  • xianyang zhang
  • Vice Chairman and Director of Shenzhen Huakang, Director of KingGrace
  • --
  • liqi zhou
  • Group Chief Financial Officer, Company Secretary
  • --
  • jianhua fu
  • Deputy General Manager and Chief Technology Officer of Shenzhen Huakang
  • --
Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.